Multi-Institutional Prospective Cohort Study of Patients With Pulmonary Hypertension Associated With Respiratory Diseases

202158 citationsJournal Articlediamond Open Access

Authors

Nobuhiro Tanabe · Chiba University

Hiraku Kumamaru · The University of Tokyo

Yuichi Tamura · Mita Hospital

Hiroyuki Taniguchi · Tosei General Hospital

Noriaki Emoto · Kobe Pharmaceutical University

Yoshihito Yamada · JR Tokyo General Hospital

Osamu Nishiyama ·

Abstract

This first Japanese registry of R-PH showed that a high proportion of patients with MVI (PAH phenotype) had better survival if they received initial treatment with PAH-targeted therapies. Responders were predominant in the group with MVI.

Topics & Keywords

Pulmonary Hypertension Research and Treatments Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis Heart Failure Treatment and Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Circulation Journal

Volume 85, Issue 4, pp. 333-342

DOI: 10.1253/circj.cj-20-0939

Field-Weighted Citation Impact: 7.72